ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "bone remodeling"

  • Abstract Number: 1771 • 2019 ACR/ARP Annual Meeting

    MyD88 S209R Enhances Inflammation in Mouse Models of Arthritis

    Sufia Bakshi1, Anders Lindstedt 2, Malika Waschmann 3, Wanxia Tsai 1, Robert Colbert 4 and Keith Sikora 1, 1National Institutes of Health, Bethesda, MD, 2NIH, Bethesda, MD, 3Oregon Health and Science University, Portland, OR, 4Pediatric Clinical Trials Unit, Pediatric Translational Research Branch, NIAMS, NIH, Bethesda, MD

    Background/Purpose: MyD88 is a critical adaptor protein that connects Toll-like and IL-1 receptor signaling to activation of NF-kB. We previously reported a heterozygous de novo gain-of-function mutation in MYD88 (S222R)…
  • Abstract Number: 1989 • 2019 ACR/ARP Annual Meeting

    Netrin-1 and Its Receptor Unc5B Mediates Tenofovir Induced Bone Loss and Dipyridamole, an Agent That Blocks Adenosine Transporter, Is Able to Modulate the Signal

    Aranzazu Mediero1, Patricia Llamas-Granda 2, Bruce Cronstein 3, Raquel Largo 4 and Gabriel Herrero-Beaumont 4, 1IIS-FUNDACION JIMENEZ DIAZ, Madrid, Spain, 2IIS-FUNDACION JIMENEX DIAZ, Madrid, Spain, 3Department of Medicine, Division of Rheumatology NYUSoM, NYC, 4IIS-Fundación Jiménez Díaz, Madrid, Madrid, Spain

    Background/Purpose: Osteopenia and fragility fractures have been associated with HIV infection. Tenofovir, a common antiviral in HIV treatment, also leads to increases in bone catabolism…
  • Abstract Number: 1990 • 2019 ACR/ARP Annual Meeting

    Tenofovir Modulates Semaphorin 4D Signaling and Regulates Bone Homeostasis, Which Can Be Counteracted by Dipyridamole and Adenosine A2A Receptor

    Aranzazu Mediero1, Patricia Llamas-Granda 2, Bruce Cronstein 3, Raquel Largo 4 and Gabriel Herrero-Beaumont 4, 1IIS-FUNDACION JIMENEZ DIAZ, Madrid, Spain, 2IIS-FUNDACION JIMENEX DIAZ, Madrid, Spain, 3Department of Medicine, Division of Rheumatology NYUSoM, NYC, 4IIS-Fundación Jiménez Díaz, Madrid, Madrid, Spain

    Background/Purpose: Semaphorins (Sema) are a family of proteins associated with neuronal development and guidance. Sema4D/CD100 was first identified as a regulator of immune response in…
  • Abstract Number: 2192 • 2019 ACR/ARP Annual Meeting

    Stabilization of Patellar Bone-Shape Correlates Significantly with Reduced Knee Pain Frequency After IA TPX-100 in Subjects with Bilateral Patellofemoral OA

    Dawn McGuire1, Michael Bowes 2, Alan Brett 2, Neil Segal 3, Meghan Miller 4, David Rosen 4 and Yoshinari Kumagai 4, 1OrthoTrophix, Orinda, CA, 2Imorphics, Manchester, England, United Kingdom, 3University of Kansas Medical Center, Kansas City, KS, 4OrthoTrophix, Oakland, CA

    Background/Purpose: Based on data from the Osteoarthritis Initiative (OAI), MRI-based analyses of bone shape changes in the knee predict symptomatic and radiographic progression of knee…
  • Abstract Number: 2215 • 2019 ACR/ARP Annual Meeting

    Modeling-Based Bone Formation Persists in the Femoral Neck Despite Remodeling Inhibition in Subjects Treated with Denosumab

    David Dempster1, Peter Butler 2, Mathias Bostrom 3, Jeri Nieves 1, Hua Zhou 4, Li Chen 2, Nicola Pannacciulli 2, Rachel Wagman 2 and Felicia Cosman 1, 1Columbia University, New York, NY, 2Amgen Inc., Thousand Oaks, CA, 3Hospital for Special Surgery, New York, NY, 4Helen Hayes Hospital, West Haverstraw, NY

    Background/Purpose: Denosumab (DMAb) is a potent antiresorptive agent, but findings in non-human primates suggest that modeling-based bone formation (MBBF) may persist despite DMAb treatment (Ominsky…
  • Abstract Number: 61 • 2017 ACR/ARHP Annual Meeting

    Resolution of Systemic Joint Inflammatory Processes and Regeneration of Existing Bone Damage upon TNF Blockade As Monitored By In Vivo Multimodal PET-CT Imaging in Progressed Experimental Arthritis

    Silvia Hayer1, Markus Zeilinger2,3, Volker Weiss3,4, Markus Seibt5, Birgit Niederreiter1, Tetyana Shvets6, Monika Dumanic6, Florian Pichler6, Marcus Hacker6, Josef S. Smolen7, Kurt Redlich8 and Markus Mitterhauser6, 1Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, 2Faulty of Engineering, University of Applied Sciences, Winer Neustadt, Austria, 3Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria, 4Faculty of Engineering, University of Applied Sciences, Wiener Neustadt, Austria, 5Department Internal Medicine III, Division Rheumatology, Medical University of Vienna, Vienna, Austria, 6Medical University of Vienna, Vienna, Austria, 7Medical University Vienna, Division of Rheumatology, Department of Internal Medicine III, Vienna, Austria, 8Division of Rheumatology, Medical University of Vienna, Vienna, Austria

    Background/Purpose: To use in vivo multimodal [18F]FDG (fluoro-D-glucose, tracer for inflammation) and [18F]Sodium Fluoride (bone tracer) positron emission tomography/computed tomography (PET-CT) imaging for the monitoring…
  • Abstract Number: 1944 • 2017 ACR/ARHP Annual Meeting

    A Dual Role for IL-23 Receptor Signaling in Normal Bone Remodeling Versus Inflammation-Mediated Bone Damage during Arthritis

    Wida Razawy1, Marijke Koedam2, Patrick Asmawidjaja3, Anne-Marie Otten-Mus4, Bram van der Eerden2 and Erik Lubberts3, 1Rheumatology and Immunology, Erasmus MC, Rotterdam, Netherlands, 2Internal Medicine, Erasmus MC, Rotterdam, Netherlands, 3Rheumatology and Immunology, Erasmus MC, University Medical Center, Rotterdam, Netherlands, 4Immunology, Erasmus MC, University Medical Center, Rotterdam, Netherlands

    Background/Purpose: The interleukin (IL)-23/IL-17A immune pathway is critical for the development of autoimmune arthritis. Systemic exposure of IL-23 induced chronic arthritis, increased osteoclast differentiation and…
  • Abstract Number: 325 • 2016 ACR/ARHP Annual Meeting

    Ebselen Is a Potential Anti-Osteoporosis Agent By Suppressing RANK Ligand-Induced Osteoclast Differentiation in Vitro and Lipopolysaccharide-Induced Inflammatory Bone Destruction In Vivo

    Changhoon Lee1, Jong Min Baek2, Ju-Young Kim2, Won-Seok Lee3, Wan-Hee Yoo4, Myeung Su Lee5 and ACR authors group, 1Division of Rheumatology, Department of Internal Medicine, Wonkwang University Hospital, Iksan, Korea, The Republic of, 2Department of Anatomy, School of Medicine, Wonkwang University, Iksan, South Korea, 3Division of Rheumatology, Department of Internal Medicine, Chonbuk National University Medical School and Research Institute of Clinical Medicine of Chonbuk National University Hospital-Chonbuk National University, jeonju, South Korea, 4Division of Rhuematology, Department of Internal Medicine, Chonbuk National University Medical School and Research Institute of Clinical Medicine of Chonbuk National University Hospital-Chonbuk National University, Jeonju, South Korea, 5Division of Rheumatology, Department of Internal Medicine, Wonkwang University Hospital, Iksan, Chonbuk, South Korea

    Background/Purpose:  Ebselen is a non-toxic seleno-organic drug with anti-inflammatory and antioxidant properties that is currently being examined in clinical trials to prevent and treat various diseases,…
  • Abstract Number: 690 • 2016 ACR/ARHP Annual Meeting

    Increase in Serum Leptin Levels Is Associated with Radiographic Progression of Male Patients with Ankylosing Spondylitis: A 2-Year Longitudinal Study

    Seung-Geun Lee1, Eun-Kyoung Park2, Ji-Heh Park1, Hee-Sang Tag3 and Geun-Tae Kim4, 1Internal Medicine, Pusan National University School of Medicine, Pusan National University Hospital, Busan, Korea, The Republic of, 2Division of Rheumatology, Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea, The Republic of, 3Division of Rheumatology, Department of Internal Medicine, Kosin University College of Medicine, Busan, South Korea, 4Kosin University College of Medicine, Busan, South Korea

    Background/Purpose:  The immunomodulatory effects of adipokines have been extensively studied in rheumatic diseases, there is a paucity of information regarding their effects on bone metabolism.…
  • Abstract Number: 728 • 2016 ACR/ARHP Annual Meeting

    Correlation Between the Spinal MRI Findings and the Serum Level of DKK-1 in Patients with Spondyloarthritis Treated with TNF Antagonist

    Zheng Zhao, Gang Wang, Yanyan Wang, Jinshui Yang, Jian Zhu and Feng Huang, Rheumatology, Chinese PLA General Hospital, Beijing, China

    Background/Purpose : Recent prospective data suggest that spinal inflammatory damage in patients with ankylosing spondylitis will eventually convert into fat. In these complex inflammatory lesions,…
  • Abstract Number: 2206 • 2015 ACR/ARHP Annual Meeting

    Dopamine Pathway and Bone Metabolism in Arthritis

    Silvia Capellino1, Klaus W. Frommer1, Markus Rickert2, Jürgen Steinmeyer3, Stefan Rehart4, Ulf Müller-Ladner1 and Elena Neumann1, 1Internal Medicine and Rheumatology, Justus-Liebig-University of Giessen, Kerckhoff-Klinik, Bad Nauheim, Germany, 2Dept of Orthopedics and Orthopedic Surgery, University Hospital of Giessen and Marburg, Gießen, Germany, 3Dept Orthopedics and Experimental Orthopedics, University Hospital of Giessen and Marburg, Giessen, Germany, 4Orthopedics and Trauma Surgery, Markus-Hospital, Frankfurt, Germany

    Background/Purpose: A body of studies demonstrates the influence of the nervous system on the immune response. We recently described that dopamine, a neurotransmitter of the…
  • Abstract Number: 2215 • 2015 ACR/ARHP Annual Meeting

    Ticagrelor Regulates Osteoblast and Osteoclast Function and Promotes Bone Formation in Vivo By Increasing Adenosine Levels 

    Aranzazu Mediero1, Tuere Wilder2, Carl Whatling3 and Bruce Cronstein4, 1Medicine, Divison of Translational Medicine, NYU School of Medicine, New York City, NY, 2Dept of Med, Div of Rheum, NYU School of Medicine, New York, NY, 3CVMD Innovative Medicine Unit, Translational Sciences, AstraZeneca R&D, Mölndal, Sweden, 4Medicine, Division of Rheumatology, NYU School of Medicine, NEW YORK, NY

    Background/Purpose: The antiplatelet drugs Ticagrelor and clopidogrel are P2Y12 antagonists but ticagrelor also inhibits cellular adenosine uptake via ENT1 and thereby increases extracellular adenosine levels.…
  • Abstract Number: 1215 • 2014 ACR/ARHP Annual Meeting

    Circulating Mediators of Bone Remodeling in Patients with Tophaceous Gout

    Ashika Chhana1, Opetaia Aati2, Gregory Gamble2, Karen E. Callon1, Anthony Doyle3, Mark Roger4, Fiona M. McQueen5, Anne Horne2, Ian R. Reid2, Jillian Cornish1 and Nicola Dalbeth2, 1Medicine, University of Auckland, Auckland, New Zealand, 2Department of Medicine, University of Auckland, Auckland, New Zealand, 3University of Auckland, Auckland, New Zealand, 4Department of Radiology, Auckland District Health Board, Auckland, New Zealand, 5Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand

    Background/Purpose: Disordered bone remodeling has been implicated in the development of bone erosion in tophaceous gout.  The function of bone cells in the skeleton is…
  • Abstract Number: 36 • 2014 ACR/ARHP Annual Meeting

    The Use of Three-Dimensionally Printed β-Tricalcium Phosphate/Hydroxyapatite to Further Understand the Regulation of Adenosine Receptors in Osteoclast Formation and Promotion in Bone Regeneration

    Stephanie Ishack1, Aranzazu Mediero1, John Ricci2 and Bruce N. Cronstein3, 1Medicine, Division of Translational Medicine, NYU School of Medicine, New York, NY, 2Biomaterials, NYU Dental School, New York, NY, 3NYU School of Medicine, Division of Rheumatology, New York, NY

    Background/Purpose Bone defects resulting from trauma or infection need timely and effective treatments to restore damaged bone. Using specialized three-dimensional (3-D) printing technology, combined with…
  • Abstract Number: 28 • 2014 ACR/ARHP Annual Meeting

    Evidence for Receptor Activator of NF-Kb (RANK)-Independent Bone Erosion in the Cherubism Mouse Model of Inflammatory Arthritis

    William R. O'Brien1, Julia F. Charles2, Kelly Tsang1 and Antonios O. Aliprantis1, 1Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 2Rheumatology, Allergy and Immunology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

    Background/Purpose: A gain-of-function mutation in the adaptor Src Homology 3 Binding Protein 2 (SH3BP2) causes Cherubism, a rare pediatric disease marked by aggressive bone remodeling…
  • 1
  • 2
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology